🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Chinese PE Multimodality Imaging Artificial Intelligence Study

Recruitingn/aAges 14 Years - anyAllChina-Japan Friendship Hospital
NCT06526468 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 14 Years and older * Patients suspected of PE Exclusion Criteria: * Pregnant women * Refuse to follow up * Incomplete or discontinued imaging scans * Insufficient quality of image data to allow for analysis
💊

What it tests

  • Artificial Intelligence
📍

Where

1 site
China-Japan Frendship hospital
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy